Asensus Surgical (ASXC) to Release Quarterly Earnings on Thursday

Asensus Surgical (NYSEAMERICAN:ASXC - Get Free Report) is scheduled to be posting its quarterly earnings results on Thursday, February 29th.

Asensus Surgical Stock Up 2.8 %

NYSEAMERICAN:ASXC opened at $0.31 on Wednesday. Asensus Surgical has a fifty-two week low of $0.20 and a fifty-two week high of $0.86.

Hedge Funds Weigh In On Asensus Surgical

A number of large investors have recently bought and sold shares of ASXC. Virtu Financial LLC acquired a new position in Asensus Surgical during the second quarter worth $30,000. JPMorgan Chase & Co. acquired a new stake in shares of Asensus Surgical during the 1st quarter valued at approximately $31,000. FMR LLC lifted its position in shares of Asensus Surgical by 444.2% during the 1st quarter. FMR LLC now owns 48,584 shares of the company's stock valued at $32,000 after acquiring an additional 39,656 shares during the period. Ergoteles LLC purchased a new stake in shares of Asensus Surgical during the 1st quarter worth approximately $36,000. Finally, Two Sigma Investments LP acquired a new stake in shares of Asensus Surgical in the 1st quarter worth approximately $44,000. Hedge funds and other institutional investors own 10.06% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on ASXC shares. HC Wainwright reissued a "buy" rating and issued a $2.00 target price on shares of Asensus Surgical in a report on Wednesday, November 15th. Cantor Fitzgerald downgraded Asensus Surgical from an "overweight" rating to a "neutral" rating in a report on Thursday, November 16th.

About Asensus Surgical

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.